Brought to you by 
Mirum goes public via $69.75mm IPO
Jul 2019
Executive Summary
Mirum Pharmaceuticals Inc. (liver disease therapies) netted $69.75mm through its initial public offering of 5mm common shares at $15, the midpoint of its $14-16 intended range.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Mirum goes public via $69.75mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice